Smart Medical Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Global Smart Medical Devices Market Size & Trends and It is Segmented by Product Type (Diagnostic and Monitoring and Therapeutic Devices), End User (Hospitals/Clinics, Home-Care Setting, and More), by Connectivity (Bluetooth, Wi-Fi, and More), by Distribution Channel (Offline and Online), and Geography. The Market Provides the Value (in USD Million) for the Above Segments.

Global Smart Medical Devices Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Global Smart Medical Devices Market with other markets in Healthcare Industry

Global Smart Medical Devices Market Analysis by Mordor Intelligence

The smart medical devices market size stands at USD 90.54 billion in 2025 and is forecast to reach USD 185.55 billion by 2030, advancing at a 12.8% CAGR. Continuous progress in artificial intelligence, edge-enabled 5G connectivity and miniaturized sensors is allowing clinicians to pair near-real-time diagnostics with long-range data sharing. Regulatory clarity has improved as the FDA’s 2025 draft guidance sets performance baselines for software-as-a-medical-device, which in turn is lowering investment risk and encouraging broader product pipelines. Accelerating demand for at-home chronic-disease management, combined with large technology firms collaborating with established device makers, is reshaping distribution models and shortening upgrade cycles. Hospitals are using connectivity to reduce readmissions, while value-based payment policies reward providers that deploy continuous monitoring to demonstrate measurable outcome gains. Semiconductor constraints and cybersecurity obligations still add cost pressure, yet component innovation and subscription pricing are helping to offset capital hurdles for smaller facilities.

Key Report Takeaways

  • By product type, diagnostic and monitoring devices captured 63.54% of the smart medical devices market share in 2024, while therapeutic devices are projected to post the quickest CAGR through 2030. 
  • By end user, hospitals and clinics accounted for 46.21% of the smart medical devices market size in 2024; home-care settings are growing the fastest at 13.93% CAGR. 
  • By connectivity, Bluetooth held 35.72% revenue in 2024, whereas cellular/5G platforms record the steepest adoption curve over the forecast horizon. 
  • By geography, North America led with 43.53% share in 2024; Asia-Pacific is the fastest-expanding region at a 15.34% CAGR to 2030.

Segment Analysis

By Product Type: Diagnostics Drive Innovation Leadership

Diagnostic and monitoring devices accounted for 63.54% of the smart medical devices market share in 2024, a lead built on the proven clinical utility of continuous glucose and cardiac rhythm monitors. AI-enhanced dermatology scanners such as DermaSensor report 96% sensitivity for common skin cancers, speeding specialist referrals and steering treatment earlier in the disease course. Implantable loop recorders that stream arrhythmia data directly to cardiologists now feature smart-alert hierarchies that lower false positives by learning patient-specific signal patterns. Blood-pressure cuffs and pulse oximeters maintain traction in both acute and home settings as telehealth reimbursement normalizes episodic vitals capture. 

Therapeutic devices, while representing a smaller revenue base, incorporate adaptive dosing and closed-loop feedback that improve outcomes in insulin therapy, neuromodulation and rehabilitative orthopedics. Simplera CGM’s seamless integration with the MiniMed 780G insulin pump shows how firms combine diagnostic insight and automated therapy in one ecosystem. Spinal cord stimulators with onboard AI categorize pain signatures in real time, allowing clinicians to tailor signal frequencies without repeated clinic visits. Smart hearing aids analyze environmental acoustics and adjust gain instantaneously, a feature that elevates speech intelligibility for complex soundscapes and aligns with demographic ageing trends. 

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By End User: Hospitals Lead, Home Care Accelerates

Hospitals and clinics represented 46.21% of the smart medical devices market size in 2024, capitalizing on existing telemetry infrastructure and specialized care teams hhs.gov. Smart-hospital blueprints in China integrate IoT sensors, automated drug dispensing and AI triage algorithms within unified command centers that cut administrative task time by 30%. U.S. Accountable Care Organizations deploy remote monitoring kits upon discharge to reduce 30-day readmissions, an initiative shown to save USD 390 million across 2024 program participants. 

Home-care settings post the fastest 13.93% CAGR as ageing populations and reimbursement parity for telehealth expand remote-first care pathways. Adjustable beds with embedded respiratory monitors feed data into cloud dashboards where nurses can adjust CPAP settings without a home visit. Direct-to-patient shipment of mobile ECG patches bypasses traditional durable medical-equipment distributors and accelerates therapy initiation. Ambulatory centers and emergency medical services also integrate portable ultrasound and blood-gas analyzers that synchronize to electronic records before the patient reaches the hospital bay, reducing door-to-intervention times.

By Connectivity: Bluetooth Dominance Through Security Excellence

Bluetooth held 35.72% revenue in 2024 on the strength of its low-energy profile and mandated AES encryption, features that align with healthcare’s strict battery-life and privacy demands. Firmware updates over the air have become routine, helping providers close vulnerability windows without withdrawing devices from service. Bluetooth-ready vitals monitors auto-pair with clinician tablets, cutting ward installation time and freeing biomedical staff for higher-value tasks. 

Cellular and dedicated 5G modules record the sharpest growth as governments invest in nationwide coverage and network slicing. Real-time ambulance telemetry streams high-resolution ultrasound to hospitals, allowing surgical teams to prep bays before patient arrival. LPWAN formats such as NB-IoT and LoRa serve asset-tracking tags and in-home fall detectors where multi-year battery life is critical. Wi-Fi continues to support bandwidth-heavy modalities like intraoperative imaging and telepresence robotics but cedes some share to private 5G where hospitals seek deterministic latency.

Market Share
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Distribution Channel: Digital Transformation Reshapes Access

Offline channels retained 58.45% of 2024 revenue through hospital pharmacies and specialty distributors that bundle user training and post-installation service. Group purchasing organizations negotiate multi-year contracts that stabilize supply forecasts and leverage fleet-management portals to monitor device utilization. Institutional buyers still dominate high-acuity equipment where clinical validation and technical support are essential for risk mitigation. 

E-commerce expands fastest, lifting online penetration to 14.72% in 2024 as manufacturers open direct stores that feature subscription bundles and teleconsultation add-ons. Consumers select blood-pressure cuffs and fingertip oximeters after viewing comparative dashboards that rank accuracy and compatibility with mobile apps. Digital checkout shortens lead times, and integrated financing spreads payments over the device life cycle, a model attractive to home-care agencies. Regulatory agencies urge marketplaces to flag devices with FDA clearance, ensuring shoppers differentiate between wellness gadgets and regulated medical products.

Geography Analysis

North America held 43.53% of the smart medical devices market in 2024, supported by advanced reimbursement structures and an AI strategic plan that guides public-sector procurement and algorithmic fairness audits hhs.gov. Digital-health investment totaled USD 3 billion in Q1 2025, channeled into startup accelerators partnering directly with university medical centers. Canada’s Pan-Canadian AI Health Strategy promotes standards-based data exchange across provinces, while Mexico’s medical-device export corridors supply cost-effective assembly resources and maintain duty-free status under USMCA.

Asia-Pacific registers the steepest 15.34% CAGR between 2025 and 2030. China’s Trinity smart-hospital program ties state funding to quantified improvements in patient throughput by mandating integrated digital registries and 5G bedside terminals. India’s Ayushman Bharat Digital Mission issues unique health IDs, enabling longitudinal records that simplify device-generated data ingestion into national platforms. Japan’s Medical DX initiative standardizes electronic medical records across 4,000 hospitals and launches nationwide online qualification checks, aligning device interoperability protocols to international FHIR specifications. Singapore’s Synapxe links public institutions with community clinics, piloting fall-detection wearables for seniors that triggered 2,300 timely interventions during 2024 trials.

Europe remains a steady adopter thanks to the Medical Device Regulation’s post-market surveillance rules and GDPR’s strict consent frameworks that boost patient trust. National telehealth agencies integrate outcome dashboards that rank remote-monitoring programs and allocate incentives accordingly. Middle East & Africa and South America trail in installed base but show double-digit growth as infrastructure projects extend broadband coverage and private insurance options proliferate. Development banks are channeling concessional finance into regional OEM assembly plants, aiming to localize supply and cut foreign-exchange exposure.

Smart Medical Devices Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The smart medical devices industry shows moderate consolidation; top manufacturers pursue adjacent acquisitions while forging coopetition agreements that blur historic rivalries. Johnson & Johnson acquired Abiomed for USD 16.6 billion to secure percutaneous heart-pump technology and complement its electrophysiology line. Boston Scientific purchased Silk Road Medical for USD 1.26 billion, adding transcarotid stent systems that address rising stroke prevention demand. Abbott and Medtronic inked a global partnership that melds Abbott’s continuous glucose monitors with Medtronic insulin pumps, targeting the 11 million patients requiring intensive insulin therapy worldwide.

Interoperability openness emerges as a competitive wedge. Device makers expose APIs that allow third-party analytics to read raw sensor data, accelerating the build-out of specialty algorithm marketplaces. Start-ups such as Oura demonstrate that niche form factors can unlock new engagement models; its smart ring’s AI-based sleep-quality coach rolled out in March 2025 and reached 1.2 million subscriptions within nine months. Cybersecurity capabilities determine contract wins: vendors pre-install hardware root-of-trust modules and commit to 10-year patch windows that satisfy tightened procurement checklists. Patent mapping indicates white-space opportunities in battery-free implant power and real-time metabolite sensing, areas where incumbent portfolios remain thin and venture funding flows rapidly.

Global Smart Medical Devices Industry Leaders

  1. Fitbit Inc.

  2. Medtronic Plc

  3. F. Hoffmann-La Roche Ltd

  4. Omron Corporation

  5. Abbott Laboratories

  6. *Disclaimer: Major Players sorted in no particular order
Smart Medical Devices Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • August 2024: Sonova launched Audéo Infinio and Audéo Sphere Infinio hearing aids that process ambient sound through real-time AI on a new low-power chip.
  • May 2024: Masimo partnered with Medable to integrate MightySat Rx pulse oximeters into oncology trials spanning 3,000 patients across 25 countries.
  • May 2024: WS Audiology opened an R&D hub in Hyderabad, India, to expand AI-driven signal-processing research
  • October 2023: Demant’s Audika brand acquired Goed Hulpmiddelen’s audiology business to deepen its Belgian presence.

Table of Contents for Global Smart Medical Devices Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Smartphone-Enabled & Wireless Adoption Surge
    • 4.2.2 Rapid Technological Breakthroughs In Sensors & Ai
    • 4.2.3 Rising Fitness & Wellness Awareness
    • 4.2.4 Growing Chronic-Disease Burden (Diabetes, Cvd)
    • 4.2.5 5G + Edge-Ai Enabling Real-Time Remote Diagnostics
    • 4.2.6 Value-Based Reimbursement Rewarding Continuous Monitoring
  • 4.3 Market Restraints
    • 4.3.1 High Device Acquisition & Maintenance Cost
    • 4.3.2 Patient-Data Privacy & Cybersecurity Risk
    • 4.3.3 Reimbursement Lag For Ai-Driven Diagnostic Algorithms
    • 4.3.4 Sensor-Grade Semiconductor Supply Chain Bottlenecks
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Bargaining Power of Suppliers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value)

  • 5.1 By Product Type
    • 5.1.1 Diagnostic & Monitoring Devices
    • 5.1.1.1 Blood Glucose Monitors
    • 5.1.1.2 Continuous Glucose Monitors
    • 5.1.1.3 Heart-Rate Monitors
    • 5.1.1.4 Pulse Oximeters
    • 5.1.1.5 Blood-Pressure Monitors
    • 5.1.1.6 Breath Analyzers
    • 5.1.1.7 Other Diagnostic & Monitoring
    • 5.1.2 Therapeutic Devices
    • 5.1.2.1 Portable O₂ Concentrators & Ventilators
    • 5.1.2.2 Insulin Pumps (Traditional, Patch, Smart)
    • 5.1.2.3 Hearing Aids (Smart & AI-enabled)
    • 5.1.2.4 Smart Orthopedic & Other Therapeutic
  • 5.2 By End User
    • 5.2.1 Hospitals & Clinics
    • 5.2.2 Home-Care Settings
    • 5.2.3 Ambulatory & Emergency Services
    • 5.2.4 Others (Sports Medicine, Military, etc.)
  • 5.3 By Connectivity
    • 5.3.1 Bluetooth
    • 5.3.2 Wi-Fi
    • 5.3.3 Cellular/5G
    • 5.3.4 LPWAN (NB-IoT, LoRa)
  • 5.4 By Distribution Channel
    • 5.4.1 Offline (Hospital Pharmacies, Retail)
    • 5.4.2 Online (e-Commerce, DTC)
  • 5.5 By Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East & Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East & Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
    • 6.3.1 Abbott Laboratories
    • 6.3.2 Apple Inc.
    • 6.3.3 Medtronic PLC
    • 6.3.4 Dexcom Inc.
    • 6.3.5 F. Hoffmann-La Roche Ltd
    • 6.3.6 Samsung Electronics
    • 6.3.7 Fitbit (Google)
    • 6.3.8 Omron Corporation
    • 6.3.9 Philips N.V.
    • 6.3.10 Garmin Ltd
    • 6.3.11 Huawei Technologies
    • 6.3.12 Xiaomi Corp.
    • 6.3.13 ResMed
    • 6.3.14 Masimo Corporation
    • 6.3.15 iRhythm Technologies
    • 6.3.16 AliveCor Inc.
    • 6.3.17 Senseonics
    • 6.3.18 Withings
    • 6.3.19 NeuroMetrix Inc.
    • 6.3.20 Bio-Beat
    • 6.3.21 VitalConnect
    • 6.3.22 Otsuka Holdings Co. Ltd

7. Market Opportunities & Future Outlook

  • 7.1 White-Space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Smart Medical Devices Market Report Scope

As per the scope of the report, smart medical devices are equipped with the technology for ease of monitoring health or portability of the same, which enables a person to carry it anywhere.

The smart medical devices market is segmented by product type (diagnostic and monitoring and therapeutic devices), end user (hospitals/clinics, home-care settings, and others), and geography (North America, Europe, Asia-Pacific, the Middle-East and Africa, and South America). The Market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values (in USD million) for the above segments.

By Product Type Diagnostic & Monitoring Devices Blood Glucose Monitors
Continuous Glucose Monitors
Heart-Rate Monitors
Pulse Oximeters
Blood-Pressure Monitors
Breath Analyzers
Other Diagnostic & Monitoring
Therapeutic Devices Portable O₂ Concentrators & Ventilators
Insulin Pumps (Traditional, Patch, Smart)
Hearing Aids (Smart & AI-enabled)
Smart Orthopedic & Other Therapeutic
By End User Hospitals & Clinics
Home-Care Settings
Ambulatory & Emergency Services
Others (Sports Medicine, Military, etc.)
By Connectivity Bluetooth
Wi-Fi
Cellular/5G
LPWAN (NB-IoT, LoRa)
By Distribution Channel Offline (Hospital Pharmacies, Retail)
Online (e-Commerce, DTC)
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
By Product Type
Diagnostic & Monitoring Devices Blood Glucose Monitors
Continuous Glucose Monitors
Heart-Rate Monitors
Pulse Oximeters
Blood-Pressure Monitors
Breath Analyzers
Other Diagnostic & Monitoring
Therapeutic Devices Portable O₂ Concentrators & Ventilators
Insulin Pumps (Traditional, Patch, Smart)
Hearing Aids (Smart & AI-enabled)
Smart Orthopedic & Other Therapeutic
By End User
Hospitals & Clinics
Home-Care Settings
Ambulatory & Emergency Services
Others (Sports Medicine, Military, etc.)
By Connectivity
Bluetooth
Wi-Fi
Cellular/5G
LPWAN (NB-IoT, LoRa)
By Distribution Channel
Offline (Hospital Pharmacies, Retail)
Online (e-Commerce, DTC)
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current Global Smart Medical Devices Market size?

The smart medical devices market size stands at USD 90.54 billion in 2025.

Who are the key players in Global Smart Medical Devices Market?

Fitbit Inc., Medtronic Plc, F. Hoffmann-La Roche Ltd, Omron Corporation and Abbott Laboratories are the major companies operating in the Global Smart Medical Devices Market.

Which is the fastest growing region in Global Smart Medical Devices Market?

Government-backed digital-health programs and large ageing populations are driving a 15.34% CAGR in Asia-Pacific.

What role does 5G play in smart medical devices?

5G connectivity lowers data-transfer latency below clinical thresholds, enabling real-time remote diagnostics and emergency response.

Page last updated on: June 25, 2025

Global Smart Medical Devices Market Report Snapshots